Panlong Pharmaceutical
002864----
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Panlong Pharmaceutical(002864) the Revenue is 222.54 M (-11.06%);the EBIT is 29.77 M (+0.68%);the EPS is 0.21 (-30%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.22B11.06%
----
----
EBIT
0.03B0.68%
----
----
EPS
0.2130.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf